Eli Lilly shares fall after fake verified account tweets 'insulin is free now'Proactive Investors • 11/11/22
Eli Lilly Clarifies It's Not Offering Free Insulin After Tweet From Fake Verified Account—As Chaos Unfolds On TwitterForbes • 11/10/22
Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney diseaseBusiness Wire • 11/04/22
AKOUOS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUSPRNewsWire • 11/03/22
Loxo@Lilly Announces Details of Presentations at the 2022 American Society of Hematology Annual MeetingPRNewsWire • 11/03/22
Lilly's new diabetes drug doubled sales expectations. It may also be used to treat obesityMarket Watch • 11/01/22
Why Eli Lilly's Third-Quarter Beat Wasn't Enough To Save Its GuidanceInvestors Business Daily • 11/01/22
Lilly's new Type 2 diabetes drug had $187 million in sales in the third quarterMarket Watch • 11/01/22
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline ProgressPRNewsWire • 11/01/22